Stem Cell Therapy in India — What You Need to Know
This page gives you the full picture: where stem cell therapy legally stands in India today, what it can and cannot currently do, and what your options are – including paths beyond stem cells.
Stem cell therapy in India is approved as standard care – via hematopoietic stem cell transplantation (HSCT) – for 32 specific blood and immune conditions, including leukaemia, thalassaemia, and aplastic anaemia. For all other conditions (autism, cerebral palsy, kidney disease, and others), it is legally available only through registered clinical trials. MedicoExperts facilitates approved treatment and provides honest counselling for research-stage conditions.
Where Stem Cell Therapy Stands, Legally, in India
The 32 Approved Conditions
Only hematopoietic stem cell transplantation (HSCT) is recommended as Standard of Care in India. Mesenchymal stem cell (MSC) therapy is not recommended for any disease condition. The following conditions are covered by the ICMR advisory, tagged by the patient age group to which each approval applies.
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Peripheral T-cell Lymphoma, Hodgkin’s Lymphoma, Multiple Myeloma, Acquired Severe Aplastic Anemia, Constitutional Severe Aplastic Anemia, Aplastic Anemia / Paroxysmal Nocturnal Hemoglobinuria, Germ Cell Tumors, Multiple Sclerosis, Systemic Sclerosis.
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myeloid Leukemia, Myelodysplastic Syndromes / Juvenile Myelomonocytic Leukemia, Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Primary Immunodeficiency Diseases, Mucopolysaccharidoses, Thalassemia / Sickle Cell Disease, Osteopetrosis, Acquired Severe Aplastic Anemia, Inherited Bone Marrow Failure Syndromes, Ewing’s Sarcoma, Neuroblastoma.
(Reference: Hematopoietic Cell Transplantation Guidelines 2021, Annexure I — [Source: ICMR/NMC Advisory, 25 March 2026])
Why Mesenchymal Stem Cell (MSC) Therapy Is Not Approved for Any Condition
MSC therapy – the type most commonly marketed for orthopaedic, neurological, and other non-blood conditions – has not been approved by Indian regulators as a standard treatment for any disease, regardless of the condition. Any current use of MSC therapy in India is legally permitted only within a registered clinical trial.
What “Research-Only” Means in Practice
For conditions outside the 32-condition list, stem cell therapy is only available through an approved clinical trial. This requires each of the following before any treatment can proceed:
- Prior approval is required from either CDSCO (for more-than-minimally-manipulated cells) or DHR and the National Stem Cell Research Regulation Committee (for minimally manipulated cells).
- Clearance must be obtained from a DHR-registered Institutional Ethics Committee.
- Written informed consent must be obtained from the patient.
- All protocols must comply with ICMR ethical guidelines.
What Non-Compliance Means
Any stem cell treatment offered outside the approved list, or without CDSCO or DHR approval, is considered non-compliant under current regulations and can expose the treating practitioner or institution to regulatory action under Indian law.
Understanding Stem Cell Therapy — What It Is and How It Works
What Is a Stem Cell?
Stem cells are the body’s master cells, with two unique properties that set them apart from every other cell type. First, they can self-renew – dividing to produce more stem cells. Second, they can differentiate – transforming into specialised cells such as blood cells, brain cells, heart muscle cells, bone cells, and skin cells.
Your life journey begins with a single stem cell called a zygote. That one cell divides and multiplies, and its daughter cells gradually take on the specialised functions that build every organ and tissue in your body. In clinical settings, stem cells can also be harvested and administered to support tissue repair and regeneration, which is the basis of stem cell therapy.
The new cells produced by stem cells are called daughter cells, and they can be generated either naturally inside the body or in a laboratory setting before being administered to a patient.
What are the different types of stem cells?
You already know that stem cells can multiply and they either remain as stem cells or transform into specialized cells. This special power of stem cells allows us to divide them into the following five types:
Totipotent cells have the greatest developmental potential of any cell – they can become any cell type in the body, including placental cells. They are formed in the first 3–4 days after fertilisation. The zygote (fertilised egg) is the most well-known example. Totipotent cells are not used directly in clinical therapy due to ethical and regulatory constraints.
Pluripotent cells can differentiate into more than 220 different adult cell types. They begin developing from the sixth week of embryo development. Embryonic cells and fetal cells are examples of pluripotent stem cells.
Multipotent cells can produce multiple related cell types within a specific tissue or organ, giving them an important role in tissue repair, maintenance, and regeneration. Bone marrow cells, umbilical cord cells, and mesenchymal cells are examples of multipotent stem cells.
Oligopotent cells can self-renew and differentiate into only a small number of closely related cell types.
Unipotent cells are the most restricted type; they can self-renew but differentiate into only a single cell type. Adipose stem cells, extracted from fat tissue, are an example.
What are the sources of stem cells?
There are different sources of stem cells, such as:
- Bone marrow (stem cells extracted directly from the marrow cavity)
- The umbilical cord (contains two types: hematopoietic stem cells [HSCs] and mesenchymal stem cells [MSCs])
- Placental tissue (an organ that forms during pregnancy)
- Embryonic tissues (from fertilised eggs)
- Fetal tissues (sourced after spontaneous abortion or stillbirth under strict ethical guidelines)
- Adult tissues (found throughout the body after maturity)
- Differentiated somatic cells (such as skin and muscle cells, which can be reprogrammed)
What Regenerative Medicine Is — and How Stem Cell Therapy Fits In
Regenerative medicine is the broader field that encompasses stem cell therapy. Its goal is to replace, repair, or renew damaged cells, tissues, and organs – addressing the underlying cause of a condition rather than only managing its symptoms. Stem cell therapy is one tool within regenerative medicine, alongside tissue engineering and artificial organ development.
How the Procedure Generally Works
The stem cell treatment process broadly follows four stages, whether for an approved HSCT protocol or within a registered clinical trial:
Step 1 — Consultation and Assessment:
A thorough medical review is conducted to assess the patient’s condition, confirm eligibility, and determine the most appropriate protocol.
Step 2 — Stem Cell Extraction and Processing:
Stem cells are sourced using safe and ethically approved methods. The most common sources for HSCT are bone marrow and peripheral blood; for research-stage protocols, adipose tissue and umbilical cord tissue are also used.
Step 3 — Administration:
Stem cells are delivered via the method appropriate to the condition — most commonly intravenous (IV) infusion for systemic conditions, direct injection for orthopaedic or localised conditions, or intra-spinal administration for neurological conditions.
Step 4 — Recovery and Follow-Up:
Post-procedure monitoring includes lifestyle guidance, regular follow-up consultations, and physical therapy where appropriate.
For approved HSCT conditions, all of the above follows an established, well-documented protocol. For research-stage conditions, the same broad steps apply within the clinical trial framework.
Benefits — What Is Established Versus What Is Still Being Studied
Established Benefits (Human Trial Evidence)
For the 32 approved conditions listed above, hematopoietic stem cell transplantation is a mature, evidence-based treatment with decades of clinical data.
Outcomes such as transfusion independence in thalassaemia and disease remission in leukaemia and lymphoma are well-documented in peer-reviewed clinical literature and corroborated by ICMR guidelines.
For bone marrow transplantation specifically, the link to the dedicated MedicoExperts page provides condition-specific outcome data: Bone Marrow Transplantation in India →
Reported Benefits in Research Settings (Early-Stage Evidence)
For conditions outside the approved list, stem cell approaches remain an active area of research. Some early-phase clinical trials and case series have noted positive outcomes in conditions such as cerebral palsy, spinal cord injury, and chronic kidney disease.
These findings are preliminary — none is yet established as consistent or guaranteed at a population level.
Evidence labelling used on this page:
- ✅ Human trial evidence — outcomes demonstrated in peer-reviewed controlled trials
- ⚠️ Early-stage / case series evidence — outcomes noted in small studies or case reports; not yet replicable at scale
- 📋 Traditional use / expert consensus — longstanding clinical or traditional practice without controlled trial support
Specific evidence levels for individual conditions are covered on each condition’s dedicated page. Results differ from person to person, and one patient’s experience should not be taken as what every patient can expect.
Risks and What Remains Unknown
Documented side effects in both approved HSCT treatment and research-stage protocols include mild swelling or fatigue that typically resolves within a few days.
Some patients have also experienced mild fever, nausea, vomiting, bruising, or tingling and numbness. Your treating physician will review the specific risk profile relevant to your condition and protocol before proceeding.
For approved HSCT, the risk profile is well-characterised – your specialist can walk you through condition-specific data. For research-stage protocols, the risk profile is less predictable and forms part of the informed consent discussion.
There is currently no single standardised protocol for research-stage conditions.
Approaches continue to evolve as the science develops, and results can differ depending on the specific protocol, the practitioner, the cell source, and the individual patient.
In some documented cases, early improvements have faded over time – anywhere from six months to two years after treatment.
This variability is a core reason such uses are confined to research settings rather than routine clinical practice.
Given this variability and the absence of long-term, large-scale evidence for MSC applications, regulators require non-approved uses of stem cell therapy to proceed only within a monitored clinical trial.
This structure exists to protect patients – not to prevent access – by ensuring that outcomes are tracked, reported, and used to build the evidence base that will eventually support or rule out wider approval.
Find Your Condition
This directory links to every condition-specific page on MedicoExperts. The approved list matches the ICMR-NMC advisory exactly, tagged by age group. The research list covers conditions where clinical work is ongoing.
| Condition | Applies to | Treatment Details |
|---|---|---|
| Acute Myeloid Leukemia | Adults & Pediatrics | Blood Cancer Treatment → |
| Acute Lymphoblastic Leukemia | Adults & Pediatrics | Blood Cancer Treatment → |
| Chronic Myeloid Leukemia | Adults & Pediatrics | Blood Cancer Treatment → |
| Myelofibrosis | Adults | Blood Cancer Treatment → |
| Myelodysplastic Syndromes | Adults | Blood Cancer Treatment → |
| Chronic Lymphocytic Leukemia | Adults | Blood Cancer Treatment → |
| Diffuse Large B-cell Lymphoma | Adults | Non-Hodgkin’s Lymphoma → |
| Follicular Lymphoma | Adults | Blood Cancer Treatment → |
| Mantle Cell Lymphoma | Adults | Blood Cancer Treatment → |
| Peripheral T-cell Lymphoma | Adults | Blood Cancer Treatment → |
| Hodgkin’s Lymphoma | Adults & Pediatrics | Blood Cancer Treatment → |
| Multiple Myeloma | Adults | Blood Cancer Treatment → |
| Acquired Severe Aplastic Anemia | Adults & Pediatrics | Aplastic Anemia Treatment → |
| Constitutional Severe Aplastic Anemia | Adults | Aplastic Anemia Treatment → |
| Aplastic Anemia / Paroxysmal Nocturnal Hemoglobinuria | Adults | Aplastic Anemia Treatment → |
| Germ Cell Tumors | Adults | Book a Consultation → |
| Multiple Sclerosis | Adults | Book a Consultation → |
| Systemic Sclerosis | Adults | Book a Consultation → |
| Myelodysplastic Syndromes / Juvenile Myelomonocytic Leukemia | Pediatrics | Blood Cancer Treatment → |
| Non-Hodgkin Lymphoma | Pediatrics | Non-Hodgkin’s Lymphoma → |
| Primary Immunodeficiency Diseases | Pediatrics | Book a Consultation → |
| Mucopolysaccharidoses | Pediatrics | Book a Consultation → |
| Thalassemia / Sickle Cell Disease | Pediatrics | Thalassemia Treatment → · Sickle Cell → |
| Osteopetrosis | Pediatrics | Book a Consultation → |
| Inherited Bone Marrow Failure Syndromes | Pediatrics | Bone Marrow Transplantation → |
| Ewing’s Sarcoma | Pediatrics | Book a Consultation → |
| Neuroblastoma | Pediatrics | Book a Consultation → |
| Condition | Status | Alternative Paths Available Now |
|---|---|---|
| Autism | Research / Clinical Trials | Combination Therapy for Autism → |
| Cerebral Palsy | Research / Clinical Trials | Combination Therapy for Cerebral Palsy → |
| Muscular Dystrophy (all types) | Research / Clinical Trials | Combination Therapy for MD → |
| Chronic Kidney Disease | Research / Clinical Trials | Combination Therapy for CKD → |
| Diabetes (Type 1 & Type 2) | Research / Clinical Trials | Stem Cell for Diabetes → |
| Parkinson’s Disease | Research / Clinical Trials | Parkinson’s Treatment → |
| Erectile Dysfunction | Research / Clinical Trials | Ayurvedic Medicine for ED → · Stem Cell for ED → |
| Infertility | Research / Clinical Trials | IVF / IUI / ICSI → · Stem Cell for Infertility → |
| Knee Pain / Osteoarthritis | Research / Clinical Trials | Stem Cell for Knees → |
| Hip Pain | Research / Clinical Trials | Hip Pain Treatment → |
| Avascular Necrosis | Research / Clinical Trials | AVN Treatment → |
| Spinal Cord Injury | Research / Clinical Trials | Spinal Cord Injury → |
| Dementia | Research / Clinical Trials | Dementia → |
| Liver Cirrhosis | Research / Clinical Trials | Book a Consultation → |
| Burn Injury | Research / Clinical Trials | Burn Injury Treatment → |
| Polio | Research / Clinical Trials | Polio Treatment → |
Supportive Therapies Used Alongside Stem Cell Protocols
The following therapies are used to support and enhance the effects of stem cell treatment, either as part of an approved HSCT protocol or within a research-stage clinical trial. MedicoExperts coordinates these as part of the patient’s overall care plan.
HBOT increases oxygen delivery to tissues, supports cellular healing, and has been shown in clinical studies to boost stem cell mobilisation and activity. It also reduces inflammation, strengthens immune response, and supports tissue repair.
The dedicated MedicoExperts HBOT page provides full protocol details: Stem Cell + HBOT →
Ozone therapy increases cellular oxygenation and enhances the body’s natural healing capacity through anti-inflammatory, antibacterial, and immune-stimulating mechanisms.
It is used as an adjunct to stem cell protocols in selected cases.
Exosomes are molecular messengers that improve cellular communication and tissue repair at a microscopic level.
In clinical settings, they are being studied for their ability to reduce inflammation, stimulate regeneration, and support immune modulation — particularly in neurological, orthopaedic, and autoimmune conditions.
Note: Exosome therapy remains in the research stage.
Physiotherapy helps restore movement, strength, and flexibility following stem cell administration.
It plays a critical role in neuromuscular recovery by addressing pain, muscle rehabilitation, and mobility – particularly for patients with cerebral palsy, spinal cord injury, and orthopaedic conditions.
Occupational therapy helps patients rebuild independence in daily functional activities and adapt to any remaining physical limitations.
Behavioural therapy supports psychological wellbeing, stress management, and cognitive recovery.
These therapies are coordinated as part of the MedicoExperts patient care plan, where clinically appropriate.
How MedicoExperts Can Help
Our role differs depending on whether your condition has an approved treatment or is currently in the research stage – and we think being upfront about that difference is part of giving you honest guidance.
For Approved Conditions – End-to-End Facilitation
For the 32 conditions listed as approved by regulatory authorities, MedicoExperts supports your full journey:
- Personalised Consultation: A thorough medical review assesses your condition and confirms the most appropriate treatment approach.
- Expert Matching: You are connected with the specialist with the greatest documented experience for your specific condition – we do not route all patients to one hospital.
- Stem Cell Extraction and Processing: Using safe, ethical sourcing methods appropriate to HSCT protocols.
- Administration: Via the appropriate method for your condition.
- End-to-End Coordination: Travel, visa paperwork, accommodation, hospital logistics, and post-discharge follow-up are all managed by our team.
- Recovery and Follow-Up Care: Including lifestyle guidance, monitoring, and physical therapy coordination where appropriate.
For Research-Stage Conditions — Guidance, Not Facilitation
For conditions currently in research and clinical trials, MedicoExperts does not offer end-to-end treatment coordination, because that would not be an accurate or responsible thing to promise for a procedure that is not yet an approved treatment.
Instead, our role is to help you understand the landscape honestly so you can make your own informed decision:
- We explain the protocols different doctors and research teams follow, including how they differ in cell source, dosage, and administration method.
- We share our own experience honestly — what we have seen work, and where results have not held up over time.
- We walk you through the risks and potential outcomes in plain terms, so you get a realistic picture rather than a sales pitch.
- We provide thorough counselling — including whether a legitimate registered clinical trial might be relevant to your case, or whether an established alternative approach might suit you better right now.
If, after that conversation, you would like our help exploring a specific trial or next steps, we are glad to take that further with you — but that follows from an informed conversation, not from an upfront offer to arrange treatment.
Why Choose MedicoExperts?
MedicoExperts is a patient-first medical facilitation company specialising in connecting Indian and international patients with the right specialist, hospital, and treatment protocol for their condition – at transparent, all-inclusive pricing.
| Our Commitment | What This Means for You |
|---|---|
| Expert Matching | We do not route all patients to one hospital. Each patient is matched to the specialist with the greatest documented experience for their specific condition. |
| Transparent Pricing | All costs are communicated in writing before you commit. No hidden charges and no surprises on arrival. |
| End-to-End Coordination | From visa paperwork to airport pickup, accommodation, daily logistics, and post-discharge follow-up - we manage everything. |
| Second Opinion Policy | We actively encourage patients to seek a second medical opinion before proceeding. Confidence in your decision leads to better outcomes. |
| No Clinical Pressure | We provide information and options. The decision to proceed - and when - is always yours. |
| Post-Treatment Support | Our care does not end when you fly home. Virtual follow-ups, coordination with your home physician, and 24/7 emergency contact are standard. |
| ICMR-Compliant Protocols Only | We do not facilitate unproven, unapproved, or unethical treatments. Every protocol we coordinate has appropriate ethics committee approval. |
Other Paths Forward — Alternatives to Stem Cell Therapy
For many of the conditions on this page, established and currently accessible approaches exist outside stem cell therapy.
These are not a fallback – for many patients, they are a genuine path forward available today, while stem cell research for their specific condition continues.
Combination Therapy — MedicoExperts’ Integrative Protocol
MedicoExperts’ Combination Therapy integrates Advanced Homeopathy with customised Ayurveda into a single, unified treatment protocol designed for each patient’s specific condition.
This is not two separate treatments offered alongside each other – it is one coordinated protocol that works synergistically.
For many of the neurological and chronic conditions listed on this page, Combination Therapy is the most established, most accessible option available to patients right now.
Explore Alternatives by Condition
- Autism: Combination Therapy for Autism → · Ayurvedic Treatment for Autism → · Homeopathy for Autism →
- Cerebral Palsy: Combination Therapy for Cerebral Palsy → · Ayurvedic Treatment → · Homeopathy →
- Muscular Dystrophy: Combination Therapy for MD → · Ayurvedic Treatment → · Homeopathy →
- Chronic Kidney Disease: Combination Therapy for CKD → · Ayurveda for CKD → · Homeopathy for CKD →
- Erectile Dysfunction: Ayurvedic Medicine for ED → · Urology Treatment →
- Infertility: IVF / IUI / ICSI →
What Is the Cost of Stem Cell Therapy in India?
The cost of stem cell therapy in India starts from approximately USD 1,250 to USD 4,000 per cycle, depending on the condition being treated, the number of cycles required, the treating specialist, and the hospital.
A patient typically needs to plan for a stay of 10 to 30 days in India, depending on the protocol. In some cases, a longer stay of up to 45 days may be required.
India offers a significant cost advantage compared to Western countries for the same procedures, with no waiting time.
However, we do not publish a single cost figure for the hub page because what you pay depends entirely on your specific condition – the figures above are a starting range, not a fixed price.
You will find accurate, condition-specific cost details on each condition’s dedicated page – or we can walk you through it directly in a consultation.
How We Help International Patients
Travelling to a new country for treatment can feel daunting. MedicoExperts handle every logistical aspect of your visit so you can focus on your health:
- Submit your medical reports through the MedicoExperts free consultation form to begin the process.
- Our team contacts you immediately to review your case and clarify what additional reports may be needed.
- Our expert stem cell physicians evaluate your reports and provide a detailed assessment with treatment options.
- We prepare a personalised travel itinerary that fits your budget and comfort requirements.
- We arrange medical visa assistance and coordinate your flight details, airport pick-up, accommodation, and hospital transfers.
- You undergo your treatment at a leading hospital or centre with an experienced specialist.
- After treatment, our team provides virtual follow-up consultations, coordination with your home physician, and 24/7 support for as long as you need it.
Patient Journeys — What Our Patients Have Experienced
The patients below came to MedicoExperts seeking options for conditions that are currently in the research stage in India. Their videos reflect their personal experiences and outcomes — these are individual journeys, not guaranteed results, and their conditions were treated within the counselling and guided pathway MedicoExperts provides for research-stage conditions. Individual results vary.
Book a Consultation
Whether you are exploring approved HSCT treatment, a legitimate clinical trial pathway, or an alternative therapy such as Combination Therapy, MedicoExperts is here to give you clear, honest guidance on your options.
Frequently Asked Questions (FAQs):
Q1. Is stem cell therapy approved for every condition mentioned on this page?
No. Routine stem cell treatment – specifically hematopoietic stem cell transplantation (HSCT) – is approved in India as standard care only for the 32 blood and immune conditions listed above.
For all other conditions on this page, including autism, cerebral palsy, muscular dystrophy, chronic kidney disease, and most orthopaedic conditions, stem cell therapy is available in India only through a registered clinical trial with CDSCO or DHR approval and ethics committee sign-off.
Q2. What is the difference between HSCT and MSC therapy?
Hematopoietic stem cell transplantation (HSCT) uses blood-forming stem cells – typically sourced from bone marrow or peripheral blood – and is the only stem cell approach recognised as standard-of-care in India, and only for a specific list of blood and immune conditions.
Mesenchymal stem cell (MSC) therapy uses a different cell type, commonly sourced from bone marrow, fat tissue, or umbilical cord tissue, and is frequently marketed for orthopaedic, neurological, and other conditions.
MSC therapy is not currently approved as a standard treatment for any condition in India and is legally available only through registered clinical trials.
Q3. Is Parkinson's Disease or autism on the approved list?
Neither Parkinson’s Disease nor autism is on the ICMR-approved list for HSCT as standard care in India.
Both are currently classified as research-stage conditions, meaning stem cell therapy for these conditions is only legally available through a registered clinical trial with ethics committee approval.
MedicoExperts can help you understand whether a legitimate trial pathway is relevant to your case – and can also walk you through currently available alternative treatments, including Combination Therapy, which is accessible now.
Q4. What are the side effects of stem cell therapy?
Documented side effects in both approved HSCT treatment and research-stage settings include mild swelling or fatigue that typically resolves within a few days.
Some patients have also experienced mild fever, nausea, vomiting, bruising, or tingling and numbness.
For approved HSCT protocols, the full risk profile is well-characterised and your specialist will review it with you in detail before proceeding.
For research-stage protocols, the risk profile is discussed as part of the informed consent process.
Q5. How long does it take to see results?
For approved HSCT conditions, timelines are well-documented and condition-specific.
For thalassaemia, for example, transfusion independence is typically assessed at 3–12 months post-transplant. Your specialist will provide the relevant timeline for your specific condition.
For research-stage protocols, timelines vary by protocol and are less predictable – early improvements in some cases have faded between six months and two years after treatment, which is why monitoring within the trial framework is essential.
Q6. Will MedicoExperts arrange stem cell treatment for a condition that is not on the approved list?
No, not as a booked treatment.
For conditions outside the approved list, our role is honest counselling – explaining the protocols different doctors follow, sharing our experience, and walking you through the risks and potential outcomes, so you can reach your own informed decision.
If a legitimate registered clinical trial turns out to be relevant to you, we can help you explore that pathway. We do not offer or arrange stem cell therapy as routine treatment for non-approved conditions.
Q7. How do I know if a clinic offering stem cell therapy is operating legally?
A legally compliant clinic will be upfront about whether your condition is on the ICMR-approved list or requires clinical trial participation.
For non-approved conditions, look for clear evidence of CDSCO or DHR approval for the specific protocol, sign-off from a registered Institutional Ethics Committee, and written informed consent documentation.
If a provider offers stem cell therapy for a non-approved condition as a standard, purchasable treatment – without mentioning trial registration or ethics approval – that is a warning sign under current Indian regulations and the March 2026 advisory.
Q8. Can international patients seek stem cell treatment in India?
Yes. MedicoExperts works with international patients from more than 17 countries across 3 continents.
The cost of equivalent stem cell treatment in India is a fraction of what the same procedure costs in the USA, UK, or UAE — and there is no waiting time.
Our team handles medical visa coordination, airport pick-up, accommodation near the treatment centre, hospital logistics, post-treatment follow-up, and coordination with your home physician.
Start with a free consultation →
Q9. Are alternatives like Combination Therapy, Ayurveda, and Homeopathy proven treatments?
It depends on the condition and the specific approach.
MedicoExperts’ Combination Therapy — which integrates Advanced Homeopathy with customised Ayurveda into a single unified protocol — is for many conditions more established and more immediately accessible than experimental stem cell therapy.
That said, the evidence base varies by condition, and these approaches are not all backed by the same weight of controlled clinical trial evidence as an approved treatment like HSCT.
We would encourage discussing the evidence for your specific condition with our team before deciding on a path forward, so you can make a genuinely informed choice.
Q10. Is stem cell therapy covered by insurance in India?
Only treatments approved by regulatory bodies may be covered by insurance.
For the 32 HSCT-approved conditions, insurance coverage is possible depending on your policy.
Unapproved procedures – including MSC therapy for any condition – are not covered by standard Indian insurance policies.
Why MedicoExperts?
17
Country
3
Continent
102051
Number of Patients Served
1500
Continent
300
Network Hospitals
60
Super Specialists
MedicoExperts is a Global virtual hospital which is established to offer quality healthcare services at affordable pricing without compromising the success rates of the treatment.
MedicoExperts is having a network of highly experienced super specialist doctors and well equipped hospitals across the globe and offering second opinion through online video consultation and surgical interventions through its empanelled super specialist doctors at its network hospitals in 17 countries from 3 continents.
By the virtue of its approach and model, MedicoExperts is successfully achieve to deliver
- Latest and most advanced treatments with success rates of international benchmarks.
- Multiple cost options depending upon the hospital facilities, with the same doctor.
- Treatment option in multiple cities/state/countries.
- Trust and peace of mind.
Most suitable for patients who are looking for:-
- Planned Surgeries and treatment from most experienced doctors and at multiple cost options as per hospital facilities with best possible outcomes.
- Second Opinion from expert doctors.
- Complex cases involving multi specialities
- International patients looking for treatment from Indian doctors
Recommended Articles For You
- https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
- https://pubs.iscience.in/journal/index.php/cbl/article/view/1042
- https://www.sciencedirect.com/science/article/pii/S1934590918304880
- https://content.iospress.com/articles/stemjournal/stj210002
- https://www.aboutstemcells.org/info/stem-cell-types
- https://pubmed.ncbi.nlm.nih.gov/30900481/#:~:text=Stem%20cell%20therapy%20has%20emerged,immune%20response%20and%20promoting%20angiogenesis.
- https://www.frontiersin.org/articles/10.3389/fcvm.2022.845070/full#:~:text=Vascular%20repair%20upon%20vessel%20injury,vascular%20cells%20during%20vascular%20repair.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068820/#:~:text=New%20research%20shows%20that%20transplanted,disease%20and%20other%20neurodegenerative%20diseases.
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445610/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172584/
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621781/
- Hematopoietic Cell Transplantation Guidelines 2021, Annexure I — ICMR — https://main.icmr.nic.in/
- Declaration of Helsinki — WMA — https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/
- Stem cell sources review — PubMed — https://pubmed.ncbi.nlm.nih.gov/29563048/
- Insomnia and stem cell activity — PMC — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621781/
- Stem cell therapy in blood disorders — Frontiers in Cardiovascular Medicine — https://www.frontiersin.org/articles/10.3389/fcvm.2022.845070/full
- Neurodegenerative disease and stem cells — PMC — https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3068820/
Recommendations To Understand Different Treatments
As a parent of an autistic child, you may fear that your child may be bullied or treated differently in society. You may also fear that autism may prevent your child from living a complete and…..Read More
Do you also still believe that there is no cure for Cerebral Palsy? During one of the orthopedics surgical camps, which MedicoExperts organized in Nigeria, we met a family who approached us…..Read More
Duchenne muscular dystrophy (DMD) is an uncommon muscle disorder, yet it ranks among the most prevalent genetic conditions, impacting roughly 1 in every 3,500 male births across the globe. The symptoms of this…..Read More
Are you considering stem cell therapy for kidney failure in India but hesitating because you don’t know whether it is safe or not? We can understand your dilemma. But you should know that…..Read More
Let’s understand from one of our patient’s Alex experience of stem cell therapy for spinal cord injury in India. Alex is a 28-year-old man from Uganda. He lives in Kampala and has a wife, and 5-year-old…..Read More
Ignorance is not at all bliss when you have erectile dysfunction(ED). Yes, only 25% of the men with ED approach the doctor and take treatment. You would be surprised to know that 75% of the people…..Read More
Do you know you can avoid joint replacement surgery by stem cell therapy for knee cartilage repair and cover the expenses under insurance? Yes, You heard it Right. Say goodbye to the fear of surgery…..Read More
How can hip pain stop your monthly income, dreams, and health? Hip pain can make you bedridden if you don’t treat it at the right time. Hip pains are at times are unbearable pain and even increase during…..Read More
According to WHO, about 422 million people worldwide have diabetes, and the majority of the people live in low-and middle-income countries. Diabetes (who. int). Moreover, diabetes directly…..Read More
Have you tried everything to become pregnant and now losing hope? You must be worried that you are about to cross the age of fertility and yet not get conceived. Every woman has a desire to…..Read More
How can burn injury thrash your future dreams and plans? Sahil, a 32-year-old man from Palghar, works as an engineer in a chemical factory. He is recently married and enjoying his new life with a new…..Read More
Medically Reviewed and Clinically By MedicoExperts Editorial & Clinically Review Board
Author Bio:
Dr. Khushbu Jain is a dedicated professional with a passion for advancing healthcare through cutting-edge treatments. She has a special interest in researching regenerative medicine and advanced treatment for diseases that are difficult to treat with conventional treatment options. Her deep understanding of these progressive treatments allows her to offer patients personalized and effective solutions for a variety of health concerns.
Medical Disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your doctor or a qualified healthcare provider with any questions regarding your health. Stem cell therapy is a regulated medical procedure — suitability and eligibility must be assessed by a qualified treating physician.
